Characterization of intron-1 haplotypes of the G protein β4 subunit gene - Association with survival and progression in patients with urothelial bladder carcinoma

Pharmacogenetics and Genomics

Volumn 18, Issue 11, 2008, Pages 999-1008

  Riemann, Kathrin ^a,e   Struwe, Henrike ^a   Eisenhardt, Andreas ^b   Obermaier, Brigitte ^d   Schmid, Kurt W ^c,e   Siffert, Winfried ^a,e  

^a Institute of Pharmacogenetics   (Germany)

^b Department of Urology ^*  (Germany)

^c Institute of Pathology and Neuropathology   (Germany)

^d Eurofins Medinet Inc   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bladder; Genetics; Haplotypes; Survival; Tumor

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; EXON; FEMALE; G PROTEIN BETA4 SUBUNIT GENE; GEL MOBILITY SHIFT ASSAY; GENE; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

5' UNTRANSLATED REGIONS; AGED; CELL LINE; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GTP-BINDING PROTEIN BETA SUBUNITS; HAPLOTYPES; HUMANS; INTRONS; KAPLAN-MEIERS ESTIMATE; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 56149100913     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3283117d79     Document Type: Article

References (28)

1. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003; 24:765-781.
2. Frey UH, Eisenhardt A, Lümmen G, Rübben H, Jöckei KH, Schmid KW, et al. The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:871-877.
3. Frey UH, Lümmen G, Jäger T, Jöckel KH, Schmid KW, Rübben H, et al. The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res 2006; 12:759-763.
4. Frey UH, Alakus H, Wohlschlaeger J, Schmitz KJ, Winde G, van Calker HG, et al. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer. Clin Cancer Res 2005; 11:5071-5077.
5. Frey UH, Nückel H, Sellmann L, Siemer D, Küppers R, Düng J, et al. The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia. Clin Cancer Res 2006; 12: 5686-5692.
6. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, et al. Association of the G-protein beta 3 subunit variant with hypertension. Nat Genet 1998; 18:45-48.
7. Nückel H, Frey U, Aralh N, Dürig J, Dührsen U, Siffert W. The CC genotype of the C825T polymorphism of the G protein beta3 gene (GNB3) is associated with a high relapse rate in patients with chronic lymphocytic leukemia. Leuk Lymphoma 2003; 44:1739-1743.
8. Eisenhardt A, Siffert W, Rosskopf D, Musch M, Mosters M, Roggenbuck U, et al. Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer. World J Urol 2005; 23:279-286.
9. Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002; 51:1601-1608.
10. Rosskopf D, Busch S, Manthey I, Siffert W. G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension 2000; 36:33-41.
11. Frey UH, Hauner H, Jöckel KH, Manthey I, Brockmeyer N, Siffert W. A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Gαs protein expression and body weight regulation. Pharmacogenet Genomics 2008; 18:141-151.
12. Rosskopf D, Manthey I, Siffert W. Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding G-protein β3 subunit. Pharmacogenet 2002; 12:209-220.
13. Rosskopf D, Nikula C, Manthey I, Joisten M, Frey U, Kohnen S, et al. The human G protein β4 subunit: gene structure, expression, Gγ and effector interaction. FEBS Lett 2003; 544:27-32.
14. Bachmann HS, Siffert W, Frey UH. Successful amplification of extremely GC-rich promoter regions using a novel 'slowdown PCR' technique. Pharmacogenetics 2003; 13:759-766.
15. Sobin LH, Wittekind C. TNM classification of malignant tumours (UICC). 6th ed. New York: Wiley-Liss; 2002.
16. Ott J. Statistical genetics and linkage utility programs, 9/2006 update. http://www.genemapping.cn/linkutil.htm
17. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-265.
18. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
19. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
20. Brandt B, Meyer-Staeckling S, Schmidt H, Agelopoulos K, Buerger H. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response. Clin Cancer Res 2006; 12:7252-7260.
21. Zella LA, Kim S, Shevde NK, Pike JW. Enhancers located in the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxy-vitamin D(3). J Steroid Biochem Mol Biol 2007; 103:435-439.
22. Beohar N, Kawamoto S. Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene. Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type- and differentiation state-dependent manner. J Biol Chem 1998; 273:9168-9178.
23. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003; 35:341-348.
24. The International HapMap Project Homepage: http://www.hapmap.org/
25. Koch WJ, Hawes BE, Allen LF, Lefkowitz RJ. Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21 ras. Proc Natl Acad Sci U S A 1994; 91:12706-12710.
26. Schwindinger WF, Robishaw JD. Heterotrimeric G-protein betagamma-dimers in growth and differentiation. Oncogene 2001; 20:1653-1660.
27. Bookout AL, Finney AE, Guo R, Peppel K, Koch WJ, Daaka Y. Targeting Gβγ signaling to inhibit prostate tumor formation and growth. J Biol Chem 2003; 278:37569-37573.
28. Faivre S, Regmauld K, Bruyneel E, Nguyen QD, Mareel M, Emami S, et al. Suppression of cellular invasion by activated G-protein subunits Galphao, Galphai1, Galphai2, and Galphai3 and sequestration of Gbetagamma. Mol Pharmacol 2001; 60:363-372.